Ebola medical therapy: Difference between revisions
No edit summary |
|||
| Line 9: | Line 9: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Treatment is primarily supportive and includes: | Treatment is primarily supportive and includes: | ||
*Minimizing invasive procedures | *Minimizing invasive procedures | ||
Revision as of 21:50, 14 December 2012
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola medical therapy On the Web |
|
American Roentgen Ray Society Images of Ebola medical therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ebola is potentially lethal and since no approved vaccine or treatment is available. Treatment is primarily supportive and includes maintaining oxygen and blood levels and treating any complicating infections.
Medical Therapy
Treatment is primarily supportive and includes:
- Minimizing invasive procedures
- Balancing electrolytes since patients are frequently dehydrated
- Replacing lost coagulation factors to help stop bleeding
- Maintaining oxygen and blood levels
- Treating any complicating infections.
Convalescent Plasma (factors from those who have survived Ebola infection) shows promise as a treatment for the disease. Ribavirin is ineffective. Interferon is also thought to be ineffective. In monkeys, administration of an inhibitor of coagulation (rNAPc2) has shown some benefit, protecting 33% of infected animals from a usually 100% (for monkeys) lethal infection (unfortunately this inoculation does not work on humans). In early 2006, scientists at USAMRIID announced a 75% recovery rate after infecting four rhesus monkeys with Ebola virus and administering antisense drugs.
References